Thus, we investigated whether the pendrin inhibitor YS-01 showed a therapeutic effect in an LPS-induced ALI mouse model and also examined the mechanism underlying the effects of YS-01. This evidence concerns the gene SLC26A4 and acute respiratory distress syndrome.